Skip to main content

Table 7 Similar studies in detail

From: Permanent 125I-seed prostate brachytherapy: early prostate specific antigen value as a predictor of PSA bounce occurrence

Authors

Year

N

Age

FU

% bounce

≥ +2 ng/ml

Delay

Amplitude

Nadir

duration

Bounce cause

BF & bounce

Alternative definitions

Crook et al. [14]

2007

275

64 (45-80)

44

40

15%

15.2 (3-29)

0.76 (0.21-11.79)

--

6.8 (3-50)

Age

Delay

--

Mitchell et al. [21]

2008

205

62 (43-75)

45

37

7.5%

14.9 (1.7-40.6)

0.91 (0.2-5.8)

1.4 (0.1-6.9)

11.3 (2.3-32.5)

Age

V PSA (using Phoenix def)

--

Zwahlen et al. [34]

2010

194

62 (47-75)

60

50

11.3%

14 (0-70)

0.5 (0.2-8.3)

0.1 (0-3.5)

12 (2-43)

Age

Delay

≥ 0.4 ng/ml: 34

             

≥ 15%: 11

             

≥ 35%: 9

Mazeron (this study)

2012

198

67 (49-80)

64

36

12.7%

17 (3.6-50.2)

0.6 (0.2-5.1)

1.4 (0.02-6.6)

13.6 (4-44.9

Age

6 week PSA assessment delay

≥ 0.1 ng/ml: 49

             

≥ 15%: 52

             

≥ 35%: 36